Biotron shareholders
This website is to keep Biotron shareholders informed as to what is happening with the company and, in particular, what is happening with the proposed change of management.
Biotron was established about 25 years ago, with very promising prospects, and shares valued at $0.50.
Since then, the company has not entered into any commercial arrangements which have generated any money, and almost all the funding has come from shareholders buying further shares and rights. The company has so far spent over $60 million with no commercial benefit to date.
During June 2025, shareholders were asked to complete a survey . The responses from the survey were overwhelmingly in favour of the suggestion of the restructure of the Board of Directors, and the formation of a shareholders advisory committee.
Please click on the links below for further information.
Directors and Shareholder Advisory Committee
Note. For convenience and to save expense, this website is hosted on the website of Somerville Legal, solicitors. However, Somerville Legal has no involvement in Biotron, and Timothy Somerville no longer has any financial interest in Somerville Legal.